We are live on
!
Find out more
VC
Vestor Capital Portfolio holdings
AUM
$1.38B
1-Year Est. Return
39.2%
This Fund
S&P 500
This Quarter
Est. Return
-11.81%
1 Year Est. Return
+39.2%
3 Year Est. Return
+169.95%
5 Year Est. Return
+251.66%
10 Year Est. Return
–
AUM
$825M
AUM Growth
-$183M
(-18%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-5.19%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
245
New
15
Increased
44
Reduced
54
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$13.2M |
| 2 |
Elevance Health
ELV
|
+$12.3M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$12.2M |
| 4 |
LyondellBasell Industries
LYB
|
+$12.1M |
| 5 |
Cencora
COR
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$22.5M |
| 2 |
Microsoft
MSFT
|
+$21.2M |
| 3 |
Bank of America
BAC
|
+$13.5M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$12.1M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.33% |
| 2 | Technology | 14.33% |
| 3 | Industrials | 10.33% |
| 4 | Financials | 7.08% |
| 5 | Materials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.93T
| $52.8M | 6.4% |
386,262
-55,676
| -13% | -$8.43M |
|
|
2
Microsoft
MSFT
$2.91T
| $32.4M | 3.93% |
126,147
-78,145
| -38% | -$21.2M |
|
3
UnitedHealth
UNH
$380B
| $30.9M | 3.74% |
60,112
+109
| +0.2% | +$54.7K |
|
|
4
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
| $29.4M | 3.57% |
823,488
+303,526
| +58% | +$12.2M |
|
5
McKesson
MCK
$99.9B
| $28.5M | 3.46% |
87,380
+372
| +0.4% | +$119K |
|
6
Visa
V
$690B
| $24.5M | 2.97% |
124,445
+309
| +0.2% | +$63.9K |
|
7
State Street Financial Select Sector SPDR ETF
XLF
$56.4B
| $22.7M | 2.75% |
720,749
-263,368
| -27% | -$9.1M |
|
8
Union Pacific
UNP
$178B
| $22.5M | 2.73% |
105,391
+540
| +0.5% | +$123K |
|
9
Becton Dickinson
BDX
$44.1B
| $22M | 2.67% |
89,426
-1,536
| -2% | -$390K |
|
10
Eli Lilly
LLY
$1.07T
| $21.3M | 2.58% |
65,717
-317
| -0.5% | -$95.2K |
|
|
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $20.1M | 2.44% |
251,889
+139,348
| +124% | +$13.2M |
|
12
Canadian Pacific Kansas City
CP
$81.3B
| $18.5M | 2.24% |
264,927
+1,311
| +0.5% | +$94.9K |
|
13
Canadian National Railway
CNI
$78B
| $17.2M | 2.08% |
152,631
+524
| +0.3% | +$61.2K |
|
14
Corteva
CTVA
$58.3B
| $16.8M | 2.03% |
309,678
+2,044
| +0.7% | +$119K |
|
15
Norfolk Southern
NSC
$77.1B
| $16.6M | 2.01% |
72,926
-77
| -0.1% | -$18.9K |
|
16
AbbVie
ABBV
$458B
| $15.9M | 1.92% |
103,659
+40,595
| +64% | +$6.2M |
|
|
17
LyondellBasell Industries
LYB
$19B
| $15.8M | 1.92% |
180,718
+115,783
| +178% | +$12.1M |
|
18
Abbott
ABT
$184B
| $15.8M | 1.92% |
145,410
+1,921
| +1% | +$218K |
|
19
Broadcom
AVGO
$1.8T
| $15.7M | 1.91% |
323,970
-78,450
| -19% | -$4.4M |
|
20
PepsiCo
PEP
$191B
| $15.2M | 1.84% |
90,965
+92
| +0.1% | +$15.5K |
|
21
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $14.7M | 1.78% |
35,477
-672
| -2% | -$303K |
|
22
iShares Core S&P 500 ETF
IVV
$865B
| $14.7M | 1.78% |
38,662
-272
| -0.7% | -$112K |
|
23
Verizon
VZ
$198B
| $13.2M | 1.6% |
259,811
-378
| -0.1% | -$19.1K |
|
24
Thermo Fisher Scientific
TMO
$209B
| $13M | 1.58% |
23,912
+39
| +0.2% | +$21.5K |
|
|
25
Elevance Health
ELV
$82.1B
| $12.5M | 1.52% |
26,004
+24,779
| +2,023% | +$12.3M |
|
Similar funds
RIM
AU
AO
OCAM
JHU
FFM
NCGI
RAM
Vestor Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Vestor Capital held 245 positions worth $825M, down 18% from $1.01B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Vestor Capital withdrew a net $42.8M in Q2 2022, closing 36 positions and reducing 54 holdings. Its most notable exit was Upstart Holdings, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
Against the trend, Vestor Capital opened a new position in Cencora worth $11.1M.
- Vestor Capital's largest Q2 2022 buy was Cencora: 78,791 shares worth $11.1M.
- Vestor Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022, an estimated $13.2M increase.
- Vestor Capital's biggest Q2 2022 reduction was Alphabet (Google) Class C, cutting an estimated $22.5M.
- Vestor Capital fully exited Upstart Holdings in Q2 2022, selling an estimated $10.9M.
- Vestor Capital's ten largest holdings make up 35% of its $825M portfolio in Q2 2022.
- Vestor Capital opened 15 new positions and closed 36 in Q2 2022.
- Vestor Capital's portfolio value fell 18% quarter-over-quarter to $825M.
Based on Vestor Capital's 13F filing for Q2 2022, filed 10 Aug 2022.